New drug-delivery capsule may replace injections
Pill coated with tiny needles can deliver drugs directly into the lining of the digestive tract.
Koch Institute
High-speed biologics screen
Engineers devise technology for rapidly testing drug-delivery vehicles in zebrafish.
Biologists find an early sign of cancer
Patients show boost in certain amino acids years before diagnosis of pancreatic cancer.
Researchers engineer new mouse model to study disease
Time-saving tool takes advantage of CRISPR gene-editing technology.
Inventor creates tiny technologies for medicine; awarded $500,000 Lemelson-MIT Prize
Sangeeta Bhatia combines clinical and engineering perspectives to tackle complex health challenges.
Engineering new bone growth
Coated tissue scaffolds help the body grow new bone to repair injuries or congenital defects.
Recycling old batteries into solar cells
Proposal could divert a dangerous waste stream while producing low-cost photovoltaics.
RNA combination therapy for lung cancer offers promise for personalized medicine
Researchers improve therapeutic response in clinically relevant model of lung-tumor growth.
A new way to model cancer
New gene-editing technique allows scientists to more rapidly study the role of mutations in tumor development.
Model of viral lifecycle could help in finding a cure for hepatitis B
New technique sustains virus in liver cells, allowing study of immune response and drug treatments.
Advanced thin-film technique could deliver long-lasting medication
Nanoscale, biodegradable drug-delivery method could provide a year or more of steady doses.
Advancing medicine, layer by layer
Studies by graduate students Stephen Morton and Nisarg Shah show progress toward better cancer treatment and bone replacement.
Robert Langer receives Kyoto Prize
Institute Professor cited as "a founder of the field of tissue engineering."
Faculty highlight: Paula Hammond
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
